pubmed-article:19487592 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19487592 | lifeskim:mentions | umls-concept:C1186983 | lld:lifeskim |
pubmed-article:19487592 | lifeskim:mentions | umls-concept:C0021107 | lld:lifeskim |
pubmed-article:19487592 | lifeskim:mentions | umls-concept:C0189967 | lld:lifeskim |
pubmed-article:19487592 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
pubmed-article:19487592 | lifeskim:mentions | umls-concept:C0699733 | lld:lifeskim |
pubmed-article:19487592 | pubmed:issue | 23 | lld:pubmed |
pubmed-article:19487592 | pubmed:dateCreated | 2009-6-16 | lld:pubmed |
pubmed-article:19487592 | pubmed:abstractText | In patients with percutaneous device implantation for closure of patent foramen ovale (PFO), a 10% incidence of new or worsened aortic regurgitation within 12 months has been reported with echocardiography. Cardiac magnetic resonance imaging is a powerful noninvasive tool to quantify volume and fraction of valve insufficiencies. We studied the acute and long-term impact of percutaneous device implantation for PFO closure on valve insufficiencies in cardiac magnetic resonance imaging. | lld:pubmed |
pubmed-article:19487592 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487592 | pubmed:language | eng | lld:pubmed |
pubmed-article:19487592 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487592 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19487592 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19487592 | pubmed:month | Jun | lld:pubmed |
pubmed-article:19487592 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:19487592 | pubmed:author | pubmed-author:HombachVinzen... | lld:pubmed |
pubmed-article:19487592 | pubmed:author | pubmed-author:KochsMatthias... | lld:pubmed |
pubmed-article:19487592 | pubmed:author | pubmed-author:WöhrleJochenJ | lld:pubmed |
pubmed-article:19487592 | pubmed:author | pubmed-author:NusserThorste... | lld:pubmed |
pubmed-article:19487592 | pubmed:author | pubmed-author:SpiessJochenJ | lld:pubmed |
pubmed-article:19487592 | pubmed:author | pubmed-author:MerkleNicoN | lld:pubmed |
pubmed-article:19487592 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19487592 | pubmed:day | 16 | lld:pubmed |
pubmed-article:19487592 | pubmed:volume | 119 | lld:pubmed |
pubmed-article:19487592 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19487592 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19487592 | pubmed:pagination | 3002-8 | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:meshHeading | pubmed-meshheading:19487592... | lld:pubmed |
pubmed-article:19487592 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19487592 | pubmed:articleTitle | Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies. | lld:pubmed |
pubmed-article:19487592 | pubmed:affiliation | Department of Internal Medicine II-Cardiology, University of Ulm, Albert-Einstein-Allee 23, Ulm 89081, Germany. jochen.woehrle@uniklinik-ulm.de | lld:pubmed |
pubmed-article:19487592 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19487592 | pubmed:publicationType | Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19487592 | lld:pubmed |